Strengths

● The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.

● The group's activity appears highly profitable thanks to its outperforming net margins.

● Thanks to a sound financial situation, the firm has significant leeway for investment.

● Its low valuation, with P/E ratio at 4.77 and 6.31 for the ongoing fiscal year and 2022 respectively, makes the stock pretty attractive with regard to earnings multiples.

● The company has a low valuation given the cash flows generated by its activity.

● Over the last twelve months, the sales forecast has been frequently revised upwards.

● Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.

● For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.

● For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.

● The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

● Over the past four months, analysts' average price target has been revised upwards significantly.

● Over the past twelve months, analysts' opinions have been strongly revised upwards.

● Historically, the company has been releasing figures that are above expectations.


Weaknesses

● As estimated by analysts, this group is among those businesses with the lowest growth prospects.

● The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.

● The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.